Mus vs Tuvalu: Previously treated cases tested for RR-/MDR-TB (%)
Mus
100.0%
in 2022
Tuvalu
100.0%
in 2021
Mus rank
1st
Tuvalu rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Mus
- Tuvalu
How they compare
Mus currently reports 100.0% against 100.0% in Tuvalu, a difference of 0.0%.
The two have swapped places 3 times across 6 shared years of data; in 2014 it was Mus ahead.
Mus ranks 1st and Tuvalu ranks 1st of 2 regions.
Mus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mus | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 90.0% | 36.8% | 53.2% | Mus |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mus or Tuvalu?
- Mus, at 100.0% against 100.0% in Tuvalu as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mus and Tuvalu?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Tuvalu?
- 6 years are reported by both, from 2014 to 2021.
- How do Mus and Tuvalu rank globally for previously treated cases tested for rr-/mdr-tb?
- Mus ranks 1st and Tuvalu ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.